Literature DB >> 5322143

Hemolysis in immune rabbits of autologous erythrocytes modified with common enterobacterial antigen.

T Suzuki, E A Gorzynski, H Y Whang, E Neter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1964        PMID: 5322143     DOI: 10.1007/BF02151248

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  3 in total

1.  SURVIVAL IN IMMUNE AND NONIMMUNE RABBITS OF CR51-LABELED ERYTHROCYTES MODIFIED BY BACTERIAL ANTIGEN.

Authors:  C N SHUMWAY; V BOKKENHEUSER; D POLLOCK; E NETER
Journal:  J Lab Clin Med       Date:  1963-10

2.  [Hemolytic crisis in immune animals following transfusion of homologous serum sensitized in vitro by specific bacterial antigen].

Authors:  R CEPPELLINI; M DE GREGORIO
Journal:  Boll Ist Sieroter Milan       Date:  1953 Nov-Dec

3.  Immunological studies of a heterogenetic enterobacterial antigen (Kunin).

Authors:  H Y WHANG; E NETER
Journal:  J Bacteriol       Date:  1962-12       Impact factor: 3.490

  3 in total
  5 in total

1.  DIFFERENCES IN ANTIBODY RESPONSE OF RABBIT TO INTRAVENOUSLY INJECTED SOLUBLE AND CELL-ATTACHED ENTEROBACTERIAL ANTIGEN.

Authors:  E NETER; H Y WHANG; T SUZUKI; E A GORZYNSKI
Journal:  Immunology       Date:  1964-11       Impact factor: 7.397

Review 2.  Enterobacterial common antigen.

Authors:  P H Mäkelä; H Mayer
Journal:  Bacteriol Rev       Date:  1976-09

3.  Effect of erythrocytes treated with enterobacterial common antigen on experimental Salmonella typhimurium infection of mice.

Authors:  E A Gorzynski; S A Krasny
Journal:  Med Microbiol Immunol       Date:  1975-07-02       Impact factor: 3.402

4.  SELECTIVE DESTRUCTION BY PSEUDOMONAS AERUGINOSA OF COMMON ANTIGEN OF ENTEROBACTERIACEAE.

Authors:  H Y WHANG; E NETER
Journal:  J Bacteriol       Date:  1964-11       Impact factor: 3.490

5.  Opsonizing and bactericidal activity of antibodies against common antigen of Enterobacteriaceae.

Authors:  G J Domingue; E Neter
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.